Despite the well-known sex dimorphism in cardiovascular disease traits, the exact genetic,
molecular, and cellular underpinnings of these differences are not well understood. A …

While the received traditional predictors are still the mainstay in the diagnosis and prognosis
of CVD events, increasing studies have focused on exploring the ancillary effect of …

Obesity and related metabolic diseases show clear sex-related differences. The growing
burden of these diseases calls for better understanding of the age-and sex-related metabolic …

Objectives: To test whether recently developed methods for comprehensive profiling of the
high-density lipoprotein (HDL) glycome combined with the HDL proteome can distinguish …

Purpose Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an inflammatory biomarker
secreted in the atherosclerotic plaque. Blood levels of Lp-PLA2 predict future cardiovascular …

Platelet-activating factor (PAF), a proinflammatory lipid mediator, plays a crucial role in the
formation of the atherosclerotic plaque. Therefore, the inhibition of endothelium inflammation …

A marked increase in the frequency of obesity at the population level has resulted in an
increasing number of obese women entering pregnancy. The increasing realization of the …

Objective To explore associations between lipoprotein-associated phospholipase A2 (Lp-
PLA2) and the risk of cardiovascular events in a Chinese population, with a long-term follow …

BACKGROUND: Lipoprotein association phospholipase A2 (Lp-PLA2), an enzyme which
has been found in atherosclerotic plaque is currently under investigation in large Phase III …

Objective—Levels of acute phase reactants are affected by age. The extent to which
cardiovascular risk associated with aging is due to an increase in the inflammatory burden is …